128 related articles for article (PubMed ID: 1726093)
41. Characterization of promoter elements of an interferon-inducible Ly-6E/A differentiation antigen, which is expressed on activated T cells and hematopoietic stem cells.
Khan KD; Lindwall G; Maher SE; Bothwell AL
Mol Cell Biol; 1990 Oct; 10(10):5150-9. PubMed ID: 1697928
[TBL] [Abstract][Full Text] [Related]
42. The immunosuppressive macrolides FK-506 and rapamycin.
Thomson AW
Immunol Lett; 1991 Jul; 29(1-2):105-11. PubMed ID: 1717376
[TBL] [Abstract][Full Text] [Related]
43. FK-506 and cyclosporin A: selective inhibition of calcium ionophore-induced polymorphonuclear leukocyte degranulation.
Forrest MJ; Jewell ME; Koo GC; Sigal NH
Biochem Pharmacol; 1991 Aug; 42(6):1221-8. PubMed ID: 1716098
[TBL] [Abstract][Full Text] [Related]
44. Ly-6 A/E antigen of murine T cells is associated with a distinct pathway of activation. Requirements for interferon and exogenous interleukin 2.
Toulon M; Palfree RG; Palfree S; Dumont FJ; Hämmerling U
Eur J Immunol; 1988 Jun; 18(6):937-42. PubMed ID: 2454826
[TBL] [Abstract][Full Text] [Related]
45. Phenotypic changes induced by interferon in resting T cells: major enhancement of Ly-6 antigen expression.
Dumont FJ; Palfree RG; Coker LZ
J Immunol; 1986 Jul; 137(1):201-10. PubMed ID: 2423601
[TBL] [Abstract][Full Text] [Related]
46. Effects of cyclosporin A, FK 506, and mycalamide A on the activation of murine CD4+ T cells by the murine B7 antigen.
Galvin F; Freeman GJ; Razi-Wolf Z; Benacerraf B; Nadler L; Reiser H
Eur J Immunol; 1993 Jan; 23(1):283-6. PubMed ID: 7678228
[TBL] [Abstract][Full Text] [Related]
47. Mode of action of FK-506 on protective immunity to Hymenolepis nana in mice.
Asano K; Taki M; Matsuo S; Yamada K
In Vivo; 1996; 10(6):537-45. PubMed ID: 8986461
[TBL] [Abstract][Full Text] [Related]
48. Calcineurin antagonists inhibit interferon-gamma production by downregulation of interleukin-18 in human mixed lymphocyte reactions.
Kuinose M; Iwagaki H; Morimoto Y; Kohka H; Kobashi K; Sadamori H; Inagaki M; Urushihara N; Yagi T; Tanaka N
Acta Med Okayama; 2000 Oct; 54(5):201-9. PubMed ID: 11061569
[TBL] [Abstract][Full Text] [Related]
49. Tepoxalin, a novel immunosuppressive agent with a different mechanism of action from cyclosporin A.
Zhou L; Ritchie D; Wang EY; Barbone AG; Argentieri D; Lau CY
J Immunol; 1994 Dec; 153(11):5026-37. PubMed ID: 7963563
[TBL] [Abstract][Full Text] [Related]
50. Interferon-alpha/beta enhances the expression of Ly-6 antigens on T cells in vivo and in vitro.
Dumont FJ; Coker LZ
Eur J Immunol; 1986 Jul; 16(7):735-40. PubMed ID: 3487457
[TBL] [Abstract][Full Text] [Related]
51. The effect of the immunosuppressant FK-506 on alternate pathways of T cell activation.
Bierer BE; Schreiber SL; Burakoff SJ
Eur J Immunol; 1991 Feb; 21(2):439-45. PubMed ID: 1705513
[TBL] [Abstract][Full Text] [Related]
52. Cyclosporin A inhibits Ca2+-mediated upregulation of the DNA repair enzyme DNA polymerase beta in human peripheral blood mononuclear cells.
Ahlers C; Kreideweiss S; Nordheim A; Rühlmann A
Eur J Biochem; 1999 Sep; 264(3):952-9. PubMed ID: 10491144
[TBL] [Abstract][Full Text] [Related]
53. Induction of T cell CD7 gene transcription by nonmitogenic ionomycin-induced transmembrane calcium flux.
Ware RE; Hart MK; Haynes BF
J Immunol; 1991 Oct; 147(8):2787-94. PubMed ID: 1717576
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of Ly-6A antigen expression prevents T cell activation.
Flood PM; Dougherty JP; Ron Y
J Exp Med; 1990 Jul; 172(1):115-20. PubMed ID: 2141625
[TBL] [Abstract][Full Text] [Related]
55. Rapamycin antagonizes cyclosporin A- and tacrolimus (FK506)-mediated augmentation of linker for activation of T cell expression in T cells.
Cho CS; Chang Z; Elkahwaji J; Scheunemann TL; Manthei ER; Colburn M; Knechtle SJ; Hamawy MM
Int Immunol; 2003 Nov; 15(11):1369-78. PubMed ID: 14565935
[TBL] [Abstract][Full Text] [Related]
56. Cyclosporin A suppresses the induction of nitric oxide synthesis in interferon-gamma-treated L929 fibroblasts.
Trajković V; Badovinac V; Janković V; Samardzic T; Maksimović D; Popadić D
Scand J Immunol; 1999 Feb; 49(2):126-30. PubMed ID: 10075015
[TBL] [Abstract][Full Text] [Related]
57. The mechanism of action of FK-506 and cyclosporin A.
Wiederrecht G; Lam E; Hung S; Martin M; Sigal N
Ann N Y Acad Sci; 1993 Nov; 696():9-19. PubMed ID: 7509138
[TBL] [Abstract][Full Text] [Related]
58. Fas antigen expression of hepatocytes and its modification by immunosuppressants.
Yokoyama I; Hayakawa A; Hayashi S; Kobayashi T; Negita M; Takagi H
Dig Dis Sci; 1997 Dec; 42(12):2471-5. PubMed ID: 9440622
[TBL] [Abstract][Full Text] [Related]
59. A dual mechanism of immunosuppression by FK-506. Differential suppression of IL-4 and IL-10 levels in T helper 2 cells.
Wang SC; Morel PA; Wang Q; Jordan ML; Simmons RL; Tweardy DJ
Transplantation; 1993 Oct; 56(4):978-85. PubMed ID: 7692640
[TBL] [Abstract][Full Text] [Related]
60. Sensitivity of whole-blood T lymphocytes in individual patients to tacrolimus (FK 506): impact of interleukin-2 mRNA expression as surrogate measure of immunosuppressive effect.
Härtel C; Schumacher N; Fricke L; Ebel B; Kirchner H; Müller-Steinhardt M
Clin Chem; 2004 Jan; 50(1):141-51. PubMed ID: 14709642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
